SANOFI INDIA
|
|
BOM : 500674     NSE : SANOFI     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Jul 06,2022 |
Price(EOD): ₹ 6,485.80
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 14,917.34 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
SANOFI INDIA | 0.4% | -5% | -16.7% |
SUN PHARMACEUTICAL INDUSTRIES | -0.3% | -3% | 21% |
DIVIS LABORATORIES | 0.7% | 3.1% | -16.5% |
DR REDDYS LABORATORIES | 0.6% | 1.9% | -19.6% |
CIPLA | -0.8% | -3.9% | -4.9% |
GLAND PHARMA | -4.6% | -11.1% | -23% |
PIRAMAL ENTERPRISES | 2% | -5.5% | -29.9% |
CADILA HEALTHCARE | 1.5% | -0.9% | -43.6% |
TORRENT PHARMACEUTICALS | 1.8% | 4.2% | -0.7% |
FUNDAMENTAL ANALYSIS OF SANOFI INDIA
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SANOFI INDIA
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
15.8
P/E Calculated based on EPS of 410.61
[ Dec2021 - Standalone Results ] 6.89
P/B Calculated based on Book Value of 941.52
[ Dec2021 - Standalone Results ] 5.08
P/S Calculated based on Revenues of 2938.5 Cr
[ TTM - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
28% 14% 19% |
SHARE PRICE MOMENTUM OF SANOFI INDIA
SANOFI INDIA vs SENSEX
DEBT OF SANOFI INDIA
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0 0 0 - |
- - - - |
[Last Annual Data : Dec2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF SANOFI INDIA
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF SANOFI INDIA
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
2.78% 52.91% 146.37% 163.72% |
-2.5% 2.69% 67.11% 63.4% |
QtrlyTrend |
6 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
SANOFI INDIA related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 0.2% | -1.2% | -14.9% |
S&P BSE SMALL CAP | 0.2% | -5.2% | -0.9% |
S&P BSE 400 MIDSMALLCAP | 0.1% | -4.5% | -2% |
S&P BSE 150 MIDCAP | 0% | -4.1% | -1.2% |
S&P BSE ALLCAP | -0% | -4.4% | 0.1% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MNC | 1.4% | -0.4% | 2.5% |
NIFTY MID SMALL400 | 0.1% | -4.6% | -1.4% |
NIFTY MIDCAP150 | 0.1% | -4% | -0.5% |
NIFTY500 MULTICAP 50:25:25 | 0% | -4.7% | -0.7% |
NIFTY LARGE MIDCAP 250 | 0% | -4.1% | -0.1% |
You may also like the below Video Courses
FAQ about SANOFI INDIA
Is SANOFI INDIA good for long term investment?
As on Jul 06,2022, the Fundamentals of SANOFI INDIA look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of SANOFI INDIA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SANOFI INDIA UnderValued or OverValued?
As on Jul 06,2022, SANOFI INDIA is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of SANOFI INDIA ?
As on Jul 06,2022, the Intrinsic Value of SANOFI INDIA is Rs. 5,455.26 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 5,070.30
Fair Value [Median EV / Sales Model] : Rs. 5,665.61
Fair Value [Median Price / Sales Model] : Rs. 5,455.26
Median Fair Value of SANOFI INDIA : Rs. 5,455.26
Is SANOFI INDIA trading at a Premium or Discount?
As on Jul 06,2022, SANOFI INDIA is trading at a Premium of 19% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
